Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function
[Thomson Reuters ONE] – Landmark BLOCK HF Trial Demonstrates Clinical Benefits of Biventricular Pacing in New Patient Population MINNEAPOLIS – April 10, 2014 – Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here […]